We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Intercell Completes Equity Private Placement of EUR 15.2 Million at a Price of EUR 2.30 Per New Share

News   May 15, 2012

 
Intercell Completes Equity Private Placement of EUR 15.2 Million at a Price of EUR 2.30 Per New Share
 
 
Advertisement
 

RELATED ARTICLES

A Next-Generation Anti-Amyloid Vaccine for Alzheimer’s Disease?

News

A team led by Chuanhai Cao, PhD, of the University of South Florida Health (USF Health), has focused on overcoming, in those with impaired immunity, excess inflammation and other complications that interfere with development of a therapeutic Alzheimer’s vaccine.

READ MORE

UK Researchers Set To Explore Human Challenge Studies for COVID-19 Vaccine Development

News

Researchers are set to explore a human challenge study with the virus that causes COVID-19, the first such study anywhere in the world.

READ MORE

Significant Public Messaging Required Before COVID-19 Vaccines Are Made Available, Study Says

News

A new BYU study indicates some significant public messaging should be communicated before any COVID-19 vaccines are made available in the US. And with vaccines potentially being approved by the end of the year or early next year, the clock is ticking.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE